Showing results (81-90 of 181) with videos related to

Sort By:
Pageof 19
Blood|July 21, 2010
IgA-mediated human autoimmune hemolytic anemia as a result of hemagglutination in the spleen, but independent of complement activation and FcαRIPhilippe Chadebech, Marc Michel, Daniel Janvier, et al.
Annals of Hematology|May 8, 2010
Diagnosis and management of chronic ITP: comments from an ICIS expert groupJohn David Grainger, Paula H B Bolton-Maggs, Bertrand Godeau, et al.
British Journal of Haematology|June 25, 2014
Effect of pregnancy on the course of immune thrombocytopenia: a retrospective study of 118 pregnancies in 82 womenValentine Loustau, Odile Debouverie, Florence Canoui-Poitrine, et al.
Autoimmunity Reviews|September 4, 2014
Profound symptomatic hypogammaglobulinemia: a rare late complication after rituximab treatment for immune thrombocytopenia. Report of 3 cases and systematic review of the literatureRomain Levy, Matthieu Mahévas, Lionel Galicier, et al.
Blood|July 30, 2009
The spectrum of Evans syndrome in adults: new insight into the disease based on the analysis of 68 casesMarc Michel, Valérie Chanet, Agnès Dechartres, et al.
Virchows Archiv : an International Journal of Pathology|July 10, 2025
Repeat biopsies in membranous lupus nephritis in the era of target antigen identificationElodie Bernhard, Hamza Sakhi, Julie Oniszczuk, et al.
American Journal of Hematology|June 28, 2016
Delayed hemolytic transfusion reaction in adult sickle-cell disease: presentations, outcomes, and treatments of 99 referral center episodesAnoosha Habibi, Armand Mekontso-Dessap, Constance Guillaud, et al.
Rheumatology (Oxford, England)|August 13, 2024
Muscle involvement in systemic sclerosis: high mortality not associated with nature of histological lesionsNoémie Le Gouellec, Louai Zaidan, Benjamin Chaigne, et al.
Rheumatology (Oxford, England)|January 7, 2012
Efficacy and tolerance of infliximab in refractory Takayasu arteritis: French multicentre studyArsène Mekinian, Antoine Néel, Jean Sibilia, et al.
European Journal of Haematology|January 24, 2018
Pretreatment with standard-dose intravenous methylprednisolone does not improve outcomes in newly diagnosed immune thrombocytopenia (ITP)Anaïs Essilini, Thibault Comont, Johanne Germain, et al.
Pageof 19